Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 01/02/2026
Chief Executive Officer 49 20/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 50 -
Corporate Officer/Principal 52 31/03/2026

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 31/12/2016
Director/Board Member 60 06/05/2021
Chairman 61 04/05/2023
Director/Board Member 60 04/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 55 22/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 13 M kr
9.926 %
3,266,170 9.926 % 11 M kr
Cervantes Capital AB
9.521 %
3,132,758 9.521 % 10 M kr
5.197 %
1,710,018 5.197 % 6 M kr
4.863 %
1,600,000 4.863 % 5 M kr
NameStocks%Valuation
44.01 %
379,762 44.01 % 1 M kr
30.49 %
263,125 30.49 % 880 721 kr
Cervantes Capital AB
13.91 %
120,000 13.91 % 401 659 kr
Svea Bank AB
11.59 %
100,000 11.59 % 334 716 kr

Holdings: C-Rad AB

NameStocks%Valuation
785,5002.39% 3 M $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.com
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
-4.55%-26.32%-38.14%-27.59% 71.43M
-0.40%-2.34%+17.82%+45.91% 249B
+0.33%+0.64%+3.49%+12.96% 162B
+1.90%+6.00%-17.96%+65.92% 157B
-0.70%+2.93%-55.38%-8.86% 66.22B
+0.15%+4.09%+10.82%+65.55% 52.3B
+0.24%+0.99%-15.19%-10.88% 52.18B
-1.13%+2.85%+16.39%+28.99% 51.34B
-0.47%+0.06%+17.37%+58.29% 48.79B
-0.42%+3.83%+27.55%+77.45% 44.57B
Average -0.50%-0.60%-3.32%+30.78% 88.36B
Weighted average by Cap. +0.14%+1.50%+1.37%+38.40%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - C-Rad AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
21.00SEK
Average target price
35.00SEK
Spread / Average Target
+66.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - C-Rad AB